![]() Amarin Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases. | ![]() Genewiz GENEWIZ specializes in DNA services, including DNA sequencing, gene synthesis, molecular biology, genomic, and regulatory services. | |||
Founding Date | Founding Date 2003 | Founding Date 1915 | Founding Date 1991 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Dublin, IE HQ Mississauga, CA Vancouver, CA Lyon, FR München, DE Roscommon, IE Villa Guardia, IT see more | Locations København, DK HQ Buenos Aires, AR North Ryde, AU Wien, AT Bruxelles, BE Rio De Janeiro, BR Sofia, BG see more | Locations Dublin, IE HQ Zug, CH Bridgewater Township, US | |
Employees | Employees 2,800 | Employees 5,7072% decrease | Employees 275 | Employees 139 |
Valuation ($) | Valuation ($) 6.9 b | Valuation ($) 6.2 b | Valuation ($) 257.6 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $4.1b (FY, 2024) | Revenue (est.) kr22b (FY, 2024) | Revenue (est.) $228.6m (FY, 2024) | Revenue (est.) N/A |
Gross profit | Gross profit N/A | Gross profit kr19.5b (FY, 2024) | Gross profit $81.4m (FY, 2024) | Gross profit N/A |
Net income | Net income $560.1m (FY, 2024) | Net income kr3.1b (FY, 2024) | Net income ($82.2m) (FY, 2024) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 384.1m | Total funding raised N/A | Total funding raised $ 122.8m | Total funding raised N/A |
H. Lundbeck is a pharmaceutical company specializing in brain diseases.
View companyAmarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases.
View companyGENEWIZ specializes in DNA services, including DNA sequencing, gene synthesis, molecular biology, genomic, and regulatory services.
View company